Lab
Heartland Health Laboratories, LLC
Heartland Health Laboratories, LLC was paid $1.10M by Medicaid between Jan 2018 and Dec 2024, across 68 billing codes. Its largest line is 80053, Comprehensive metabolic panel — 13% of everything it billed.
33Billing provider infoHEARTLAND HEALTH LABORATORIES, LLC
LENEXA, KS 66219
LENEXA, KS 66219
33aNPI1619978061assigned 08/09/2005
33bProvider typeClinical Medical Laboratory
28Total paid$1.10M
24GClaims752,277
24DCodes billed68
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in Kansas
Rank by total paid#9 of 47
Median peer was paid$64K
This provider vs. median17×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 140,933 | $153K | |
| 2019 | 125,721 | $143K | |
| 2020 | 122,705 | $269K | |
| 2021 | 99,885 | $152K | |
| 2022 | 99,731 | $155K | |
| 2023 | 97,689 | $153K | |
| 2024incomplete | 65,613 | $78K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 80053 | Comprehensive metabolic panel | 13% | 48,573 | 40,487 | $141K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 10% | 1,761 | 977 | $113K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 8.2% | 50,171 | 37,396 | $90K |
| 80048 | Basic metabolic panel (calcium, ionized) | 8.0% | 41,824 | 30,878 | $89K |
| 84443 | Thyroid stimulating hormone (TSH) | 7.0% | 21,293 | 20,673 | $77K |
| 85027 | 5.6% | 32,658 | 26,726 | $61K | |
| 80061 | Lipid panel | 5.5% | 16,140 | 15,627 | $61K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 5.4% | 10,715 | 10,362 | $60K |
| 83036 | Hemoglobin; glycosylated (A1C) | 4.9% | 19,199 | 18,681 | $54K |
| 80164 | 3.1% | 8,901 | 8,163 | $34K | |
| G2024 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]) from an individual in a snf or by a laboratory on behalf of a hha, any specimen source | 2.7% | 2,028 | 1,015 | $29K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 2.6% | 17,792 | 16,509 | $29K |
56 more codes
| 87186 | 2.3% | 11,329 | $26K | |
| 83880 | 2.3% | 6,519 | $26K | |
| 82607 | 2.0% | 6,971 | $22K | |
| 85610 | 2.0% | 27,071 | $22K | |
| 87088 | 1.6% | 10,201 | $17K | |
| 80177 | 1.4% | 3,307 | $15K | |
| 81001 | 1.3% | 20,587 | $14K | |
| 82140 | 1.2% | 3,229 | $13K | |
| 84134 | 1.1% | 4,183 | $13K | |
| 83735 | 1.1% | 7,552 | $12K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 256 | $7K |
| 80076 | <1% | 2,602 | $7K | |
| 87631 | <1% | 550 | $7K | |
| 84439 | <1% | 4,140 | $6K | |
| 80185 | <1% | 1,836 | $6K | |
| 0240U | <1% | 130 | $4K | |
| 86140 | <1% | 3,341 | $4K | |
| 85651 | <1% | 3,014 | $3K | |
| G0471 | Collection of venous blood by venipuncture or urine sample by catheterization from an individual in a skilled nursing facility (snf) or by a laboratory on behalf of a home health agency (hha) | <1% | 150,801 | $3K |
| 82746 | <1% | 1,113 | $3K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 202 | $3K |
| 87077 | <1% | 988 | $3K | |
| 82728 | <1% | 1,635 | $2K | |
| 87070 | <1% | 1,307 | $2K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 19,317 | $2K |
| 83540 | <1% | 2,032 | $2K | |
| 84436 | <1% | 1,381 | $2K | |
| 80159 | <1% | 285 | $2K | |
| 82248 | <1% | 830 | $2K | |
| 87493 | <1% | 109 | $2K | |
| 83550 | <1% | 1,383 | $2K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 387 | $1K |
| 80178 | <1% | 1,482 | $1K | |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | <1% | 316 | $1K |
| 84153 | <1% | 168 | $1K | |
| 87075 | <1% | 723 | $1K | |
| P9603 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled | <1% | 172,460 | $1K |
| 80050 | General health panel | <1% | 136 | $815.04 |
| 87205 | <1% | 1,100 | $705.20 | |
| 87147 | <1% | 671 | $549.06 | |
| 80162 | <1% | 281 | $434.22 | |
| 85018 | <1% | 1,876 | $389.35 | |
| 84145 | <1% | 76 | $357.42 | |
| 84550 | <1% | 750 | $319.09 | |
| 85014 | <1% | 1,509 | $218.96 | |
| 84480 | <1% | 303 | $215.46 | |
| 80156 | <1% | 76 | $179.74 | |
| 84100 | <1% | 178 | $179.11 | |
| 83970 | <1% | 16 | $121.28 | |
| 82274 | <1% | 43 | $119.72 | |
| 87449 | <1% | 55 | $106.56 | |
| 87324 | <1% | 55 | $103.56 | |
| 80069 | <1% | 111 | $99.01 | |
| 82550 | <1% | 61 | $80.34 | |
| 84132 | <1% | 121 | $78.62 | |
| 82272 | <1% | 67 | $13.52 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialWERNER, BLAKE (DIRECTOR OF BUSINESS OPERATIONS)
| Provider | Location | Paid |
|---|---|---|
| Synergene Laboratory LLC | Houston, TX | $63K |
| Telezoe, LLC | Addison, TX | $0.00 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.